Cieśla Julia, Schulz Marcin, Krawiec Michał, Janik Michał, Wojciechowski Paweł, Dajnowska Iga, Szablewska Dominika, Bartoszek Jakub, Przywara-Chowaniec Brygida, Tomasik Andrzej
Doctoral School, Medical University of Silesia, Poniatowskiego 15, 40-055 Katowice, Poland.
School of Medicine, Medical University of Silesia, Poniatowskiego 15, 40-055 Katowice, Poland.
Nutrients. 2025 Aug 27;17(17):2786. doi: 10.3390/nu17172786.
Frailty syndrome significantly worsens the prognosis of elderly people. Sarcopenia and malnutrition are integral parts of aging, but there is a lack of knowledge about the overlap of these states, as well as their diagnostic methods and treatments. This study aimed to assess the malnutrition and sarcopenia scale in patients with frailty syndrome and the viability of evaluating the concentrations of the following potential biomarkers: albumin, total protein, and fibrinogen. A total of 170 patients >65 years were assessed for frailty using the Fried frailty scale. The risk of sarcopenia was measured using the SARC-F scale, and the risk of malnutrition was measured using the Mini Nutritional Assessment (MNA) scale. Serum albumin, protein, and fibrinogen levels were measured. The following fat-free body mass and respiratory parameters were measured: peak expiratory flow (PEF) and forced expiratory volume-one second (FEV1). A total of 53 patients were classified as robust (31%), 96 as prefrail (57%), and 21 as frail (12%) according to Fried frailty criteria. Frail patients had significantly reduced serum albumin and increased fibrinogen compared to the prefrail and robust groups ( < 0.05). A total of 38% of frail patients were at risk of sarcopenia, and 52% were at risk of malnutrition. Frail patients had lower PEF and FEV1 values, with decreases in respiratory parameters correlating with fat-free body mass and muscle strength. Frail patients are at substantial risk of malnutrition and sarcopenia. The MNA and SARC-F scales, combined with routine screening of elderly patients with frailty, may effectively identify patients with the highest risk.
衰弱综合征显著恶化老年人的预后。肌肉减少症和营养不良是衰老的组成部分,但对于这些状态的重叠情况、诊断方法及治疗缺乏了解。本研究旨在评估衰弱综合征患者的营养不良和肌肉减少症量表,以及评估以下潜在生物标志物浓度的可行性:白蛋白、总蛋白和纤维蛋白原。使用Fried衰弱量表对170名年龄>65岁的患者进行衰弱评估。使用SARC - F量表测量肌肉减少症风险,使用微型营养评定法(MNA)量表测量营养不良风险。测量血清白蛋白、蛋白质和纤维蛋白原水平。测量以下无脂肪体重和呼吸参数:呼气峰值流速(PEF)和一秒用力呼气量(FEV1)。根据Fried衰弱标准,共有53名患者被归类为健康(31%),96名患者为衰弱前期(57%),21名患者为衰弱(12%)。与衰弱前期和健康组相比,衰弱患者的血清白蛋白显著降低,纤维蛋白原升高(<0.05)。共有38%的衰弱患者有肌肉减少症风险,52%的患者有营养不良风险。衰弱患者的PEF和FEV1值较低,呼吸参数的降低与无脂肪体重和肌肉力量相关。衰弱患者存在显著的营养不良和肌肉减少症风险。MNA和SARC - F量表,结合对衰弱老年患者的常规筛查,可能有效识别风险最高的患者。